Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5160480
[patent_doc_number] => 20070173524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => '\"Novel ido inhibitors and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/550444
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13585
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550444 | IDO inhibitors and methods of use | Feb 19, 2004 | Issued |
Array
(
[id] => 7151222
[patent_doc_number] => 20040171651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex'
[patent_app_type] => new
[patent_app_number] => 10/783810
[patent_app_country] => US
[patent_app_date] => 2004-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44037
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783810 | Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | Feb 18, 2004 | Issued |
Array
(
[id] => 537254
[patent_doc_number] => 07176320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => 'Benzimidazole derivative'
[patent_app_type] => utility
[patent_app_number] => 10/777067
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24820
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777067
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777067 | Benzimidazole derivative | Feb 12, 2004 | Issued |
Array
(
[id] => 7433238
[patent_doc_number] => 20040162323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Prostaglandin D2 antagonist'
[patent_app_type] => new
[patent_app_number] => 10/780441
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6941
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780441
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780441 | Prostaglandin D2 antagonist | Feb 11, 2004 | Issued |
Array
(
[id] => 7448436
[patent_doc_number] => 20040186151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Substituted azole derivatives as therapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/777471
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65601
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777471
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777471 | Substituted azole derivatives as therapeutic agents | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7433283
[patent_doc_number] => 20040162327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Crystalline form of telmisartan sodium'
[patent_app_type] => new
[patent_app_number] => 10/777304
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4619
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162327.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777304 | Crystalline form of telmisartan sodium | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7347454
[patent_doc_number] => 20040192743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Substituted azole derivatives as therapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/777488
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83384
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777488 | Substituted azole derivatives as therapeutic agents | Feb 11, 2004 | Abandoned |
Array
(
[id] => 501220
[patent_doc_number] => 07205322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => 'Thiazolidine compounds as calcium sensing receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 10/775742
[patent_app_country] => US
[patent_app_date] => 2004-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13065
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/205/07205322.pdf
[firstpage_image] =>[orig_patent_app_number] => 10775742
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/775742 | Thiazolidine compounds as calcium sensing receptor modulators | Feb 9, 2004 | Issued |
Array
(
[id] => 7672720
[patent_doc_number] => 20040181059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents'
[patent_app_type] => new
[patent_app_number] => 10/771696
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 161287
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20040181059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771696 | Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents | Feb 3, 2004 | Issued |
Array
(
[id] => 7217110
[patent_doc_number] => 20050054705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them'
[patent_app_type] => utility
[patent_app_number] => 10/770654
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6207
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054705.pdf
[firstpage_image] =>[orig_patent_app_number] => 10770654
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/770654 | N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them | Feb 2, 2004 | Abandoned |
Array
(
[id] => 7435685
[patent_doc_number] => 20040210063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Novel 2,4-diaminothiazole derivatives'
[patent_app_type] => new
[patent_app_number] => 10/770705
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14627
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20040210063.pdf
[firstpage_image] =>[orig_patent_app_number] => 10770705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/770705 | Novel 2,4-diaminothiazole derivatives | Feb 2, 2004 | Abandoned |
Array
(
[id] => 7466893
[patent_doc_number] => 20040198779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Heterocycle substituted diphenyl leukotriene antagonists'
[patent_app_type] => new
[patent_app_number] => 10/766332
[patent_app_country] => US
[patent_app_date] => 2004-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25099
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10766332
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/766332 | Heterocycle substituted diphenyl leukotriene antagonists | Jan 27, 2004 | Abandoned |
Array
(
[id] => 645541
[patent_doc_number] => 07119115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology'
[patent_app_type] => utility
[patent_app_number] => 10/761982
[patent_app_country] => US
[patent_app_date] => 2004-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58014
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/119/07119115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10761982
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/761982 | Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology | Jan 20, 2004 | Issued |
Array
(
[id] => 532167
[patent_doc_number] => 07179832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-20
[patent_title] => 'Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/543177
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26781
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179832.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543177 | Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereof | Jan 19, 2004 | Issued |
Array
(
[id] => 5852031
[patent_doc_number] => 20060235222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Indole-derivative modulators of steroid hormone nuclear receptors'
[patent_app_type] => utility
[patent_app_number] => 10/542621
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54836
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235222.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542621 | Indole-derivative modulators of steroid hormone nuclear receptors | Jan 19, 2004 | Abandoned |
Array
(
[id] => 7239575
[patent_doc_number] => 20040157891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Inhibitor of cox'
[patent_app_type] => new
[patent_app_number] => 10/758253
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63592
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10758253
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/758253 | Inhibitor of cox | Jan 15, 2004 | Abandoned |
Array
(
[id] => 5632581
[patent_doc_number] => 20060149051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Method of preparing an acylimidazolium-type reagent'
[patent_app_type] => utility
[patent_app_number] => 10/542249
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4075
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20060149051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542249 | Method of preparing an acylimidazolium-type reagent | Jan 13, 2004 | Abandoned |
Array
(
[id] => 462106
[patent_doc_number] => RE039708
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2007-06-26
[patent_title] => 'Estrogen receptor modulators'
[patent_app_type] => reissue
[patent_app_number] => 10/757347
[patent_app_country] => US
[patent_app_date] => 2004-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51294
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10757347
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/757347 | Estrogen receptor modulators | Jan 12, 2004 | Issued |
Array
(
[id] => 5638159
[patent_doc_number] => 20060069133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Body weight gain inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/540369
[patent_app_country] => US
[patent_app_date] => 2003-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12917
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069133.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540369
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540369 | Body weight gain inhibitor | Dec 24, 2003 | Issued |
Array
(
[id] => 7122981
[patent_doc_number] => 20050014810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Use of substituted 2 phenylbenzimidazoles as medicaments'
[patent_app_type] => utility
[patent_app_number] => 10/744830
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25489
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10744830
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/744830 | Use of substituted 2 phenylbenzimidazoles as medicaments | Dec 22, 2003 | Issued |